Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Ratios

Camp4 Therapeutics (CAMP) Amortizatization of Intangibles (2024 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $480000.0 as the latest value for Q4 2025.

Quarterly Amortizatization of Intangibles rose 3.45% to $480000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 9.95% year-over-year, with the annual reading at $1.9 million for FY2025, 9.95% up from the prior year.
Amortizatization of Intangibles hit $480000.0 in Q4 2025 for Camp4 Therapeutics, down from $489000.0 in the prior quarter.
In the past five years, Amortizatization of Intangibles ranged from a high of $489000.0 in Q3 2025 to a low of $403000.0 in Q1 2024.